| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Cancer Institute (NCI) |
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001295 |
Purpose
This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.
| Condition |
|
Acquired Immunodeficiency Syndrome Neoplasm Skin Disease HIV Infections |
| MedlinePlus related topics: | AIDS Cancer Skin Conditions |
| Study Type: | Observational |
| Official Title: | Continuing Care and Treatment for Patients in the Center for Cancer Research |
| Study Start Date: | January 1992 |
| Estimated Study Completion Date: | September 2005 |
This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Eligible patients include those who have been previously enrolled on an approved NCI research protocol.
A CCR investigator decides that it is in the best interests of the patient and the NCI for the patient to be enrolled on this protocol and continue to receive care and follow-up at the NIH.
The patient or guardian signs the consent.
Contacts and Locations| Contact: NCI Referral Office | ncissc@mail.nih.gov | |
| Contact: CSSC | 8886241937 | ncicssc@mail.nih.gov |
| United States, Maryland | |||||
| National Cancer Institute (NCI) | Recruiting | ||||
| Bethesda, Maryland, United States, 20892 | |||||
More Information
NIH Clinical Center Detailed Web Page
|
| Study ID Numbers: | 920094, 92-C-0094 |
| First Received: | November 3, 1999 |
| Last Updated: | March 4, 2008 |
| ClinicalTrials.gov Identifier: | NCT00001295 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
|
